Literature DB >> 24819496

State of the art: sleeve gastrectomy.

Bettina Wölnerhanssen1, Ralph Peterli.   

Abstract

In the biliopancreatic diversion (BPD) type duodenal switch, sleeve gastrectomy was applied as the restrictive part instead of a horizontal gastrectomy in the original Scopinaro type BPD. Laparoscopic sleeve gastrectomy (LSG) was used as a first step in a staged concept for high-risk patients undergoing bariatric surgery. However, it is now being increasingly favored as a stand-alone procedure. This article discusses the history, surgical technique, early results, metabolic effects, mid- to long-term results regarding weight loss, improvement of comorbidities and quality of life, management of complications and indications. LSG is a safe and effective bariatric procedure with satisfying weight loss results and effects on comorbidities. Further data are required to assess long-term effectiveness and safety of LSG. In patients with very high initial BMI, LSG can be used in a staged concept. Other indications are: in cases with dense adhesions of the small bowel, patients with inflammatory bowel disease and patients where repeated endoscopy of the duodenum is necessary.

Entities:  

Mesh:

Year:  2014        PMID: 24819496     DOI: 10.1159/000354320

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  15 in total

Review 1.  [Management of complications after bariatric surgery].

Authors:  B Wölnerhanssen; R Peterli
Journal:  Chirurg       Date:  2015-12       Impact factor: 0.955

Review 2.  Endoscopic management of bariatric complications: A review and update.

Authors:  Caolan Walsh; Shahzeer Karmali
Journal:  World J Gastrointest Endosc       Date:  2015-05-16

3.  Laparoscopic Sleeve Gastrectomy: Investigation of Fundus Wall Thickness and Staple Height-an Observational Cohort Study : Fundus Wall Thickness and Leaks.

Authors:  Clara Boeker; Julian Mall; Christian Reetz; Kamil Yamac; Ludwig Wilkens; Christine Stroh; Hinrich Koehler
Journal:  Obes Surg       Date:  2017-12       Impact factor: 4.129

4.  Vertical Gastric Bypass with Fundectomy: Feasibility and 2-Year Follow-Up in a Series of Morbidly Obese Patients.

Authors:  Marco Antonio Zappa; Alberto Aiolfi; Cinzia Musolino; Maria Paola Giusti; Giovanni Lesti; Andrea Porta
Journal:  Obes Surg       Date:  2017-08       Impact factor: 4.129

5.  The Short-Term Renal Effects of Bariatric Surgery: A Comparative Study Between Sleeve Gastrectomy and One Anastomosis Gastric Bypass Operations Among Egyptian Patients With Severe Obesity.

Authors:  Amir I Bassiony; Alaa Sabry; Osama Shiha; Ahmed ElGeidie; Mohammed K Nassar
Journal:  Obes Surg       Date:  2020-07-23       Impact factor: 4.129

6.  A New Algorithm to Reduce the Incidence of Gastroesophageal Reflux Symptoms after Laparoscopic Sleeve Gastrectomy.

Authors:  Ilhan Ece; Huseyin Yilmaz; Fahrettin Acar; Bayram Colak; Serdar Yormaz; Mustafa Sahin
Journal:  Obes Surg       Date:  2017-06       Impact factor: 4.129

7.  The Impact of Technical Surgical Aspects on Morbidity of 984 Patients after Sleeve Gastrectomy for Morbid Obesity.

Authors:  Ohad Guetta; Amnon Ovnat; David Czeiger; Alex Vakhrushev; Gal Tsaban; Gilbert Sebbag
Journal:  Obes Surg       Date:  2017-11       Impact factor: 4.129

8.  Roux-en-Y fistulo-jejunostomy as a salvage procedure in patients with post-sleeve gastrectomy fistula: mid-term results.

Authors:  Elie Chouillard; Antoine Younan; Mubarak Alkandari; Ronald Daher; Bernard Dejonghe; Salman Alsabah; Jean Biagini
Journal:  Surg Endosc       Date:  2015-12-10       Impact factor: 4.584

9.  Re-sleeve gastrectomy as revisional bariatric procedure after biliopancreatic diversion with duodenal switch.

Authors:  Philipp C Nett; Dino Kröll; Yves Borbély
Journal:  Surg Endosc       Date:  2016-01-07       Impact factor: 4.584

10.  Indications and Long-Term Outcomes of Conversion of Sleeve Gastrectomy to Roux-en-Y Gastric Bypass.

Authors:  Antonio D'Urso; Michel Vix; Silvana Perretta; Mihaela Ignat; Louise Scheer; Didier Mutter
Journal:  Obes Surg       Date:  2021-05-01       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.